After a new agreement, the NHS will have access to transformative mRNA technology

Following the Government's agreement with Moderna to establish a cutting-edge manufacturing facility in the UK, NHS patients will now have access to the most recent technological developments, therapies, and vaccinations, including "transformative" mRNA technology.

The new manufacturing facility will ensure access to Covid-19 vaccinations as well as the capacity to create medications that specifically target conditions ....